Bend, OR, United States of America

Dan Tod Smithey

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dan Tod Smithey: Innovator in Pharmaceutical Compositions

Introduction

Dan Tod Smithey is a notable inventor based in Bend, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance drug solubility. His innovative work has led to the creation of a patent that addresses critical challenges in drug delivery.

Latest Patents

Smithey holds a patent for "Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials." This patent describes a pharmaceutical composition that comprises a solid amorphous dispersion containing a low-solubility drug and a concentration-enhancing polymer. Additionally, it includes a lipophilic microphase-forming material, which can be co-administered to improve drug efficacy in an in vivo environment. This innovation is crucial for enhancing the bioavailability of poorly soluble drugs.

Career Highlights

Dan Tod Smithey has been associated with Bend Research, Inc., where he has contributed to various projects aimed at improving pharmaceutical formulations. His expertise in creating solid amorphous dispersions has positioned him as a valuable asset in the research and development sector.

Collaborations

Throughout his career, Smithey has collaborated with several professionals, including Michael E Perlman and Ravi Mysore Shanker. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical technologies.

Conclusion

Dan Tod Smithey's work in pharmaceutical compositions exemplifies the impact of innovation in drug delivery systems. His patent and contributions to Bend Research, Inc. highlight the importance of enhancing drug solubility for better therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…